Medical Devices: Neurological Devices; Electroconvulsive Therapy Device; Establishing a Public Docket
Document ID: FDA-2009-N-0392-0001
Comments
Total: 1,276
-
Peter B. Rosenquist, M.D. - Comment
Posted : 09/16/2009 ID :FDA-2009-N-0392-0002 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Clover Leona Greene - Comment
Posted : 09/21/2009 ID :FDA-2009-N-0392-0003 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
John Zell Sadler - Comment
Posted : 09/29/2009 ID :FDA-2009-N-0392-0004 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Howard Miller M.D. - Comment
Posted : 09/29/2009 ID :FDA-2009-N-0392-0005 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Form Letter Sample 1 - [Multiple Submitters=220] - Comment re FDA-2009-N-0392-0145
Posted : 09/29/2009 ID :FDA-2009-N-0392-0006 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Coalition for the Abolition of Electroshock in Texas - Comment
Posted : 09/30/2009 ID :FDA-2009-N-0392-0007 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Glenn M Ford PE (G-M Ford & Association) - Comment
Posted : 09/30/2009 ID :FDA-2009-N-0392-0008 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Carole Frances Hayes Collier - Comment
Posted : 10/05/2009 ID :FDA-2009-N-0392-0009 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Moira Dolan, MD - Comment
Posted : 10/07/2009 ID :FDA-2009-N-0392-0010 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Greg White - Comment
Posted : 10/08/2009 ID :FDA-2009-N-0392-0011 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Eva Scholle - Comment
Posted : 10/08/2009 ID :FDA-2009-N-0392-0012 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Lynne Romans - Comment
Posted : 10/08/2009 ID :FDA-2009-N-0392-0013 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Eric Michael Balayti - Comment
Posted : 10/08/2009 ID :FDA-2009-N-0392-0014 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Steven Ferry - Comment
Posted : 10/08/2009 ID :FDA-2009-N-0392-0015 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Bonnie S. Malek - Comment
Posted : 10/08/2009 ID :FDA-2009-N-0392-0016 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Elizabeth Razminas - Comment
Posted : 10/08/2009 ID :FDA-2009-N-0392-0017 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Lourie E Pearlman - Comment
Posted : 10/09/2009 ID :FDA-2009-N-0392-0018 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Scott R. Schmidt - Comment
Posted : 10/09/2009 ID :FDA-2009-N-0392-0019 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Jerry Costley - Comment
Posted : 10/09/2009 ID :FDA-2009-N-0392-0020 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Elissa Mendenhall - Comment
Posted : 10/09/2009 ID :FDA-2009-N-0392-0021 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Robin Rachel Harstad - Comment
Posted : 10/09/2009 ID :FDA-2009-N-0392-0022 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Amy Lynn Storbakken - Comment
Posted : 10/13/2009 ID :FDA-2009-N-0392-0023 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Charles H Kellner, MD - Comment
Posted : 10/13/2009 ID :FDA-2009-N-0392-0024 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Irene O'Neill - Comment
Posted : 10/13/2009 ID :FDA-2009-N-0392-0025 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Judy Gale Sugita - Comment
Posted : 10/13/2009 ID :FDA-2009-N-0392-0026 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Jeanne Allyn Smith - Comment
Posted : 10/13/2009 ID :FDA-2009-N-0392-0027 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Kara Schleicher RN - Comment
Posted : 10/13/2009 ID :FDA-2009-N-0392-0028 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Nancy Brewer - Comment
Posted : 10/13/2009 ID :FDA-2009-N-0392-0029 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Moacyr A Rosa - Comment
Posted : 10/20/2009 ID :FDA-2009-N-0392-0030 Agency : FDA -
Jan 08,2010 11:59 PM ET
-
Herb Raymond Levine - Comment
Posted : 10/20/2009 ID :FDA-2009-N-0392-0031 Agency : FDA -
Jan 08,2010 11:59 PM ET